Public Joint-Stock Company Human Stem Cells Institute announced earnings results for the full year ended December 31, 2020. For the full year, the company announced operating income was RUB 197.966 million compared to RUB 180.522 million a year ago. Net income was RUB 72.851 million compared to RUB 84.554 million a year ago. Basic earnings per share from continuing operations was RUB 0.97 compared to RUB 1.13 a year ago.